Youngene Therapeutics Inc., Ltd.
3 clinical trials · Sponsor
◉ Watch Youngene Therapeutics Inc., Ltd.
| Record | Firm | Date |
|---|---|---|
| To Evaluate the Safety, Tolerability, and Pharmacokinetics of YG1699（Antidiabetic） in Healthy Chinese Sbjects (NCT05089617) | Youngene Therapeutics Inc., Ltd. | 2022-01-09 |
| A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes (NCT04956263) | Youngene Therapeutics Inc., Ltd. | 2021-06-17 |
| A Randomized, Double-blind, Placebo-controlled, Sequential Single and Multiple Ascending Doses of YG1699 (NCT03953092) | Youngene Therapeutics Inc., Ltd. | 2019-05-01 |
Track Youngene Therapeutics Inc., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.